Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancer.
| Image |  |
|---|---|
| Description | scientific article published on 5 January 2016 |
| Author/s |
author: Hideyuki Saya Osamu Nagano |
| Publication date | January 5, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |